Teriflunomide effective for faster-advancing MS

NATIONAL HARBOR, MD. – The approved once-daily oral immunomodulator teriflunomide is effective in reducing relapse, and worsening of relapsing forms, of multiple sclerosis (RMS) in patients with...
Source: Clinical Neurology News - Category: Neurology Source Type: news